JUDGMENT OF RECORD ·
Utah, not the FDA, now sets the first rules for AI that writes new prescriptions. Nolla's waiver lets its model prescribe acne drugs after a supervised phase.
On Oct 5 Nolla Health launched AI-issued first prescriptions for adult acne in Utah, at $4.99 a month. The signed state agreement runs 12 months. A physician approves every script for at least the first 100 patients and 4 weeks. Then the AI submits directly, with weekly review of every case to 500 patients, then monthly review of at least 10%. Topical drugs only. No isotretinoin, no oral drugs, no minors.
Utah also widened its sandbox on Oct 5, per STAT, adding pilots in prescriptions and women's health and requiring third party audits of company performance and safety claims. Doctronic and Legion Health already run refill pilots there. On Oct 6 a STAT physician essay argued that AI documentation tools push hospital bills up, citing a Blue Cross Blue Shield Association finding of hundreds of millions in added costs over two years.
The layer moving is regulation. A state licensing waiver, not an FDA clearance, now decides when software acts as the prescriber. Interface Shift governs: a patient goes from face scan to pharmacy with no visit. Confidence is Medium. The agreement is signed and live, but the formulary is narrow, volumes are small, and one state's sandbox binds no other state.
- CONFIDENCE
- Medium
- HORIZON
- 12 months, through the Utah pilot
- VS. PRIOR CALL
- New call
WHAT WOULD PROVE THIS WRONG
Utah suspends or narrows the Nolla agreement before the AI begins submitting prescriptions directly, or no second state authorizes AI-issued first prescriptions by the end of 2027.